Concepedia

Compliance With Price Transparency Rules at US National Cancer Institute–Designated Cancer Centers

Fumiko Chino, Jordan Johnson, Haley Moss

JAMA Oncology · 2021 · 26 citations · 5 references

DOIFull text

Open access

Concepts

Abstract

This cross-sectional study analyzes whether cancer centers have complied with Centers for Medicare & Medicaid Services regulations for price transparency.

References

5

Association Between Availability of a Price Transparency Tool and Outpatient Spending

Sunita Desai, Laura A. Hatfield, Andrew L. Hicks et al. · JAMA · 2016 · 139 citations · Full text

, , +17

Early Hospital Compliance With Federal Requirements for Price Transparency

Suhas Gondi, Adam L. Beckman, Avery A. Ofoje et al. · JAMA Internal Medicine · 2021 · 75 citations · Full text

, , +14

Payer-Negotiated Prices in the Diagnosis and Management of Thyroid Cancer in 2021

Roy Xiao, Vinay K. Rathi, Cary P. Gross et al. · JAMA · 2021 · 46 citations · Full text

, , +17

Analysis of Price Transparency via National Cancer Institute–Designated Cancer Centers’ Chargemasters for Prostate Cancer Radiation Therapy

Ankit Agarwal, Anupriya Dayal, Sheetal Kircher et al. · JAMA Oncology · 2020 · 43 citations · Full text

, , +17

Price Transparency—Promise and Peril

Sherry Glied · JAMA · 2021 · 34 citations · Full text

, , +14